PMC9532540_01
Summary of the four different treatment protocols received between 2019 and 2021.
fpsyt-13-986378-g001.jpg
PMC9532540_01_fpsyt-13-986378-g001.jpg
F1
The patient unfortunately did not show signs of improvement, scales remaining similar to baseline value (Figure 1). See Figure 1 for a summary of the three phases of treat.
Evolution of scores of Montgomery-Asberg depression rating scale (MADRS) and clinical global impression (CGI) rating scales. (A) Duration of repetitive transcranial magnetic stimulation (rTMS) monotherapy. (B) Duration of ketamine monotherapy. (C) Duration of combination induction phase. (D) Duration of combination consolidation phase. MADRS, Montgomery-Asberg depression rating scale; CGI, clinical global impressions scale.
fpsyt-13-986378-g002.jpg
PMC9532540_01_fpsyt-13-986378-g002.jpg
F2
See Figure 2 for timeline of events.
Detailed timeline of significant events and scores on rating scales.
fpsyt-13-986378-g003.jpg
PMC9532540_01_fpsyt-13-986378-g003.jpg
F3
See Figure 3 for a graphical representation of MADRS and CGI scores over follow-up.